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Abstract
Background: In mammals, genetically-directed cell labeling technologies have not yet been applied to the morphologic
analysis of neurons with very large and complex arbors, an application that requires extremely sparse labeling and that is
only rendered practical by limiting the labeled population to one or a few predetermined neuronal subtypes.
Methods and Findings: In the present study we have addressed this application by using CreER technology to non-
invasively label very small numbers of neurons so that their morphologies can be fully visualized. Four lines of IRES-CreER
knock-in mice were constructed to permit labeling selectively in cholinergic or catecholaminergic neurons [choline
acetyltransferase (ChAT)-IRES-CreER or tyrosine hydroxylase (TH)-IRES-CreER], predominantly in projection neurons
[neurofilament light chain (NFL)-IRES-CreER], or broadly in neurons and some glia [vesicle-associated membrane protein2
(VAMP2)-IRES-CreER]. When crossed to the Z/AP reporter and exposed to 4-hydroxytamoxifen in the early postnatal period,
the number of neurons expressing the human placental alkaline phosphatase reporter can be reproducibly lowered to
fewer than 50 per brain. Sparse Cre-mediated recombination in ChAT-IRES-CreER;Z/AP mice shows the full axonal and
dendritic arbors of individual forebrain cholinergic neurons, the first time that the complete morphologies of these very
large neurons have been revealed in any species.
Conclusions: Sparse genetically-directed, cell type-specific neuronal labeling with IRES-creER lines should prove useful for
studying a wide variety of questions in neuronal development and disease.
Citation: Rotolo T, Smallwood PM, Williams J, Nathans J (2008) Genetically-Directed, Cell Type-Specific Sparse Labeling for the Analysis of Neuronal
Morphology. PLoS ONE 3(12): e4099. doi:10.1371/journal.pone.0004099
Editor: Eshel Ben-Jacob, Tel Aviv University, Israel
Received September 23, 2008; Accepted December 2, 2008; Published December 31, 2008
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public
domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Funding: Howard Hughes Medical Institute, National Eye Institute (NIH).
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jnathans@jhmi.edu
Introduction
A central organizing principle in all nervous systems is the
division of neurons into different classes based on their distinctive
dendritic and/or axonal morphologies. This principle was first
appreciated over a century ago following the systematic analysis of
individual neuronal morphologies in Golgi stained preparations
[1]. Over the past several decades, methods for visualizing the
morphologies of individual neurons have been developed that are
based on intracellular injection of tracers such as horse-radish
peroxidase (HRP), neurobiotin or biocytin, and dextran-conjugat-
ed fluorescent dyes, or bombardment with particles coated by
carbocyanine dyes [2–5]. Labeling by intracellular injection has
the virtue that the micro-pipette used for cell filling can also be
used to characterize the neuron electrophysiologically, thereby
generating a dataset that links morphological and physiological
properties [e.g. ref. 6].
A second general strategy for visualizing neuronal morphology
relies on the selective expression of genes coding for enzymes or
fluorescent proteins. These genes can be introduced acutely into
target neurons by viral infection, electroporation, or particle
bombardment [7–10]. Although these methods are limited by the
requirement for mechanical access to the neurons of interest and
by the stochastic nature of cell targeting, they have the virtue of
being relatively rapid and applicable to virtually any experimental
animal. Alternatively, reporter genes can be introduced into the
germline or into fertilized embryos in those model organisms
amenable to such manipulation (nematodes, Drosophila, zebrafish,
Xenopus, or mice). Among germline techniques for cell marking,
‘mosaic analysis with a repressible cell marker’ (MARCM) in
Drosophila, and its cousin ‘mosaic analysis with a double marker’
(MADM) in mice, are conceptually the most general as they
produce a sparse collection of cells distinguished by the exchange
of a pre-defined chromosome arm that can carry an arbitrary set
of genetic markers [11,12].
In the mouse, genetically directed neuronal labeling has
typically been achieved by the selective expression of a fluorescent
protein or enzyme under the direct control of a cell-type-specific
promoter or under the indirect control of a pharmacologically-
regulated fusion between Cre recombinase and a mutated estrogen
receptor ligand-binding domain [CreER; 13–16]. Several imple-
mentations of the sparse labeling approach have taken advantage
of the serendipitous observation that transgenes driven by the Thy-
1 promoter often show strong position effects that restrict
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labeling density being distinctive for a given transgenic line [17–
19]. Other implementations have used BAC transgenes to produce
fluorescent proteins or Cre recombinase in a cell type specific
manner [20,21].
The mouse studies reported thus far have not applied genetic
labeling technologies to the morphologic analysis of neurons with
large and complex arbors, an application that requires extremely
sparse labeling and that is only rendered practical by limiting the
labeled population to one or a few predetermined neuronal
subtypes. In the present study we have addressed this application
by developing and characterizing a series of mouse lines that
express CreER in distinct neuronal subsets and we have used these
lines in conjunction with a plasma membrane-anchored alkaline
phosphatase reporter to visualize the morphologies of large CNS
neurons.
Results
Construction of IRES-CreER knock-in lines
To achieve sparse cell-type specific Cre-mediated recombina-
tion, we chose a strategy in which an internal ribosome entry site
(IRES) and a CreER coding region were inserted into the 39
untranslated region (UTR) of three genes that are expressed in
defined subsets of neurons and one gene that is expressed in
neurons and a subset of glia (Figure 1). For the former category we
used the genes coding for choline acetyltransferase (ChAT;
cholinergic neurons), tyrosine hydroxylase (TH; catecholaminergic
neurons), and neurofilament light chain (NFL; projection neu-
rons). For the latter category we used the gene coding for vesicle-
associated membrane protein 2 (VAMP2).
For each of the four target genes, IRES-CreER sequences were
inserted by homologous recombination in embryonic stem (ES)
cells. We chose this approach rather than conventional or bacterial
artificial chromosome (BAC) transgenesis because we presumed
that a knock-in allele would have the greatest likelihood of
precisely recapitulating the expression pattern of the endogenous
gene. Although constructing gene-targeted mouse lines is more
labor intensive than constructing BAC transgenic mice, it has the
virtue that only one knock-in mouse line needs to be characterized
for each construct. In contrast, in a transgenic approach, multiple
lines are typically characterized for each construct to assess the
effects of line-to-line variation in transgene structure, copy
number, and integration site, as this variation can affect the
expression level or lead to variegated expression. A potential
disadvantage of the knock-in strategy is that the insertion of
foreign sequences within the 39 UTR could compromise the
function of the target gene, for example by altering mRNA
transport, stability, or translation efficiency. In the present
instance, no phenotypic effects were apparent for any of the
IRES-CreER alleles in the heterozygous state or for the ChAT-
IRES-CreER, NFL-IRES-CreER,o rTH-IRES-CreER alleles in the
homozygous state. However, homozygosity for the VAMP2-IRES-
CreER allele appears to be lethal.
The strategy of inserting IRES-CreER sequences into the 39
UTR places the exogenous DNA segment at a greater distance
from the start site of transcription than would insertion of CreER
sequences in the 59 UTR, a design feature that, together with Flp-
mediated excision of the Frt-flanked Phospho-glycerate kinase
(PGK) promotor-neomycin resistance (neo) selectable marker
(‘FNF’), should minimize perturbations in gene expression in the
targeted allele (Figure 1). For the present set of four knock-in
alleles, the distances between the start site of transcription and the
point of insertion of the IRES-CreER cassette are: 57 kb (ChAT),
3.5 kb (NFL), 6.8 kb (TH), and 2.0 kb (VAMP2). As shown in
Figure 1, the IRES-CreER-FNF cassette also includes a bacterial
tetracycline resistance gene (TetR)3 9 of the CreER sequences, a
selectable marker that facilitated the identification of bacterial
colonies harboring the plasmids into which this cassette had been
inserted.
Cell type specificity of IRES-CreER expression
To characterize the cell type specificity of IRES-CreER
expression, each targeted line was crossed to the Z/AP reporter
line [22]. In the absence of Cre-mediated recombination, the Z/
AP locus ubiquitously expresses a beta-galactosidase-neo fusion
protein (beta-geo). Cre-mediated recombination excises the beta-
geo coding sequence and simultaneously activates expression of
human placental alkaline phosphatase (AP), a heat-stable enzyme
that localizes to the plasma membrane via a GPI anchor [23,24].
Previous work has shown that activation of the Z/AP reporter in
neurons leads to the efficient accumulation of AP on individual
axons and dendrites, which can be visualized by histochemical
staining [14].
Mice from the four IRES-CreER;Z/AP lines were treated with a
single dose of 4-hydroxytamoxifen (4HT) during the first two
postnatal weeks, and .1 month later tissues were harvested and
the distribution of AP revealed by histochemical staining. The
specificities of the NFL-IRES-CreER and ChAT-IRES-CreER lines
were analyzed in flatmounts of adult retina. As seen in Figure 2A,
AP-labeling in NFL-IRES-CreER;Z/AP mice is confined to retinal
ganglion cells, each of which projects an axon to the optic disc,
and less frequently to horizontal cells (not shown in Figure 2A), the
two principal cell types in the retina that express neurofilament
[25]. As seen in Figure 2C and D, AP labeling in ChAT-IRES-
CreER;Z/AP mice is confined to cholinergic (starburst) amacrine
cells, recognizable by their characteristic pinwheel morphology;
these are the only cells in the retina that express choline
acetyltransferase [26]. In the brain and retina, AP labeling in
VAMP2-IRES-CreER;Z/AP mice is observed in a wide variety of
neurons as well as in glia (Figure 2B and data not shown). Thus
far, we have not observed TH-IRES-CreER mediated Z/AP
recombination in the retina, a failure that we attribute to the
paucity of dopaminergic amacrine cells [(450 cells per mouse
retina; 27]. However, as described below, labeling in the brain in
this line is consistent with expression in catecholaminergic
neurons.
Sparse genetic labeling for visualizing neuronal
morphology
Figure 3A shows an example of sparse AP-labeling of cortical
pyramidal neurons (or parts thereof) in a 200 um thick vibratome
section from an NFL-IRES-CreER;Z/AP brain. Bright field images
at a single focal plane are shown in Figure 3B–D, and demonstrate
the clarity with which fine processes are visualized by AP
histochemistry. The scarcity of labeled neurons is evident from
the large regions of unlabeled cortex.
AP-labeled neurons can be fully reconstructed in 3-dimensions
with NIH-Image or equivalent software, as demonstrated in a
survey of retinal neurons [15]. In the present study, we have
limited the reconstruction to a two-dimensional projection in the
plane of each thick section, an image that we will refer to hereafter
as a ‘‘tracing’’ rather than a ‘‘reconstruction’’ to distinguish it from
a full three-dimensional reconstruction. This more limited analysis
has the virtue of technical simplicity, while still illustrating (albeit,
in projection) the principal morphologic features of the neurons
under analysis. Examples of neuronal tracings together with
samples of the corresponding Z-stack images from which they
Genetically-Directed Labeling
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the cortical pyramidal neuron in the 200 um section shown in
Figure 3B. The remaining panels in Figure 4 - which show a
multipolar cortical neuron (Figure 4A), cerebellar mossy fibers
(Figure 4B), cerebellar granule cells with parallel fibers (Figure 4D),
and a small cortical pyramidal neuron (Figure 4E) - are from
sections of 300 um thickness. The tracings were prepared using Z-
stacked images sampled at either 1 or 2 um intervals. As seen in
Figures 3 and 4, AP intensity varies systematically with the type
and location of neuronal processes, being heaviest in regions, such
as the soma-proximal dendrites and apical process of pyramidal
neurons, that are observed to be more intensely labeled in
neurobiotin filling experiments [28].
For retinal ganglion cells, the CreER;Z/AP method labels
dendrites, axons, and axon arbors (the latter in retino-recipient
areas in the brain) in patterns that closely match those obtained by
classical labeling methods such as diI and neurobiotin filling
(Figure 2B; ref. 15; and T.R., T. Badea, and J.N., unpublished
observations). As described below, among neurons with complex
axonal arbors extending several millimeters, we observed no
discernable variation in staining intensity within the axonal arbor.
These data suggest that the .1 month delay between 4HT
injection and sacrifice produces a roughly uniform distribution of
AP over the entire extent of an axonal or dendritic arbor.
Visualizing very large neurons in the mouse brain
The genetically-directed sparse labeling method described here
has the potential to reveal the morphologies of neurons that would
be difficult to visualize by classical cell filling methods due to their
low abundance and/or large arbor size. To explore this potential,
we have examined large neurons that were AP-labeled in mice
carrying IRES-CreER inserted in the ChAT, NFL,o rTH genes.
Figure 5A–P shows a single hemisphere from a ChAT-IRES-
CreER;Z/AP brain in which all AP-labeled processes were traced in
Figure 2. Cell-type specificity of Cre recombinase activity in mouse lines with different IRES-CreER knock-ins. The cell-type specificity of
each line was tested by crossing to the Z/AP reporter and inducing sparse recombination with 4HT. A, In the retina, the NFL-IRES-CreER line exhibits
Cre-mediated recombination in retinal ganglion cells, each of which has a single axon projecting to the optic disc, and in horizontal cells; the image
shown here shows only retinal ganglion cells. B, in the brain, the VAMP2-IRES-CreER line exhibits Cre-mediated recombination in both neurons and
glia. C and D, in the retina, the ChAT-IRES-CreER line exhibits Cre-mediated recombination exclusively in cholinergic (starburst) amacrine cells. The
region boxed in C is shown at higher magnification in D. Scale bars: 0.5 mm in A and B; 1 mm in C.
doi:10.1371/journal.pone.0004099.g002
Figure 1. Restriction maps of the targeting constructs, targeted alleles, Southern blot probes, and PCR primers for IRES-CreER
knock-in alleles at the ChAT, NFL, TH, and VAMP2 loci. For each knock-in allele, a cassette consisting of an IRES-CreER, the pBR322 Tetracycline
resistance gene (TetR), and an Frt-flanked phosphoglycerate kinase promotor neomycin resistance gene (FNF) was inserted into the 39 untranslated
region of the target gene as indicated. The PGK-neo casette was subsequently removed in vivo by Flp recombinase. The sizes of the homology
regions used for the targeting constructs were: ChAT, 9.5 kb; NFL, 7.0 kb; TH, 9.2 kb; and VAMP2, 9.1 kb. For Southern blot hybridization, the probes
indicated beneath the maps of the targeted loci were used, and genomic DNAs from the four groups of targeted ES cells and germ-line transmitted
mice were cleaved with the following restriction enzymes: ChAT, Stu I and BamHI ;NFL, EcoRV ;TH, BamH I; and VAMP2, Nco I.
doi:10.1371/journal.pone.0004099.g001
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neurons are color-coded. Sample images of the AP-stained tissue
are shown in Figures 4E and 5Q–S, and correspond to the boxed
and lettered regions in Figure 5D and J. The dendritic processes of
four AP-labeled neurons in the basal forebrain were not clearly
separable; these dendrites are colored purple in Figure 5C–E. Five
other AP-labeled neurons, such as the one pictured in Figure 5R,
have dendritic arbors that are too dense to accurately trace; these
are represented as grey territories in Figure 5A–H. The tracings in
Figure 5 show one large neuron with cortical arbors color-coded
blue (Figure 5A–H) and a second one color-coded red (Figure 5B–
N); each has an extensive axonal arbor in the cortex and a cell
body in the basal forebrain with a small number of branching
dendrites. For the two large neurons that are color-coded green
and purple, the locations of the corresponding cell bodies could
not be identified unambiguously. A striking observation from this
set of tracings is that single cholinergic neurons possess arbors that
ramify through nearly the full thickness of the cortex and extend
across .2m m
2 of cortical surface. The cortical arbors of the
neurons color coded in blue, green, red, and purple in Figure 5
span, respectively, ,2.1 mm, ,3.3 mm, ,2.1 mm, and
,3.9 mm along the rostro-caudal axis.
In the hemisphere shown in Figure 5, several contiguous zones
encompassing ,50% of the cortex are devoid of AP-labeled
processes, and in the contralateral hemisphere of this brain ,80%
of the cortex is devoid of AP label (data not shown). A similar
pattern of large and spatially clustered AP-labeled arbors was
observed in other sparsely labeled ChAT-IRES-CreER;Z/AP brains
(Figure 6). The spatial clustering of AP-labeled cortical processes
implies that these processes derive from a very small number of
neurons.
Sparse neuronal labeling was also observed in the TH-IRES-
CreER;Z/AP line following a single injection of 0.2 mg 4HT at P1.
Figure 7 shows a single AP-labeled projection neuron in a series of
15 contiguous 300 um sections from a brain that contained only
two AP-labeled cells; the second AP-labeled neuron was present in
the contralateral hemisphere and is not shown here. The cell body
of the AP-labeled neuron pictured in Figure 7 resides in the
periaqueductal gray (arrow in Figure 7N), and its axon sends out
branches along ,3 mm of its .3.6 mm rostral trajectory. The
Figure 3. Sparse recombination permits visualization of non-overlapping neuronal processes. A, 200 um vibratome section from the
brain of an NFL-IRES-CreER;Z/AP mouse injected at P0 with 0.2 mg 4HT. In this section, three large neurons (or parts of neurons) are labeled in one
hemisphere of the cerebral cortex. B–D, enlarged bright field images at one Z-plane for each of the three neurons. Scale bar: 0.5 mm.
doi:10.1371/journal.pone.0004099.g003
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(Figure 7C–F), a major target for projection neurons with cell
bodies residing in the periaqueductal gray [29].
In NFL-IRES-CreER;Z/AP mice that received a single 0.2 mg
injection of 4HT at P0, the left and right hippocampi typically
show highly asymmetric patterns of AP-labeling. For example, in
the serial 300 um coronal sections in Figure 8, in which all of the
AP-labeled processes in the hippocampus have been traced, almost
all of the AP-labeling is unilateral. These AP-labeled processes
comprise a contiguous and extensively ramifying arbor near the
surface of the molecular layer of the dentate gyrus that
encompasses the full rostro-caudal extent of the hippocampus.
The absence of other AP-labeled processes over most of the
hippocampus argues that the contiguous processes derive from a
very small number of cells, and quite possibly a single cell. In a set
of seven NFL-IRES-CreER;Z/AP brains with similarly sparse
labeling, AP-labeling within the hippocampus was confined to a
small number of compact pyramidal or granule neurons and/or to
large arbors similar to the one shown in Figure 8. In this set, two,
three, and two brains exhibited AP-labeling of the type shown in
Figure 8 within both, only one, or neither hippocampus,
respectively. Within each brain with AP-labeled hippocampi, the
labeled processes occupied a contiguous territory. The spatial
clustering of AP-labeled processes within the hippocampus is
consistent with the inference that each contiguous AP-labeled
arbor is likely derived from a single neuron.
The location, structure, and size of the large AP-labeled
hippocampal arbors closely resemble the arbors of large
hippocampal CA3 pyramidal neurons visualized by HRP,
biocytin, and neurobiotin injection [30–32]. Although it is
uncertain whether arbor filling was complete in all of these earlier
studies, the different studies are in overall agreement with respect
to the large size, extensive branching, and overall appearance of
these arbors.
Discussion
In this paper we have used the CreER technology to non-
invasively label very small numbers of neurons so that their
morphologies can be fully visualized. The four lines of IRES-CreER
knock-in mice described here permit labeling that is selective for
cholinergic or catecholaminergic neurons (TH-IRES-CreER or
ChAT-IRES-CreER), that is enriched for projection neurons (NFL-
IRES-CreER), or that is broadly targeted to neurons and some glia
(VAMP2-IRES-CreER). We note that in the context of typical
CreER-based tissue- and time-specific conditional knockout
experiments, inefficient Cre-mediated recombination of target
genes is generally considered undesirable [33]. By contrast, the
strategy presented here exploits inefficient recombination to
produce an extremely sparse collection of labeled neurons. As
demonstrated here and in ref. 14, the number of recombined
neurons can be reproducibly lowered to fewer than 50 per brain.
General properties of the CreER;Z/AP method
For genetically-directed cell labeling to be useful for the analysis
of neuronal morphology, Cre-mediated recombination following
4HT exposure should label only ,1i n1 0
4–10
8 neurons,
depending on CNS location. In the system described here, this
inefficiency arises from a combination of four factors: (1) the
relatively inefficient translation of CreER coding sequences
Figure 4. Tracing the morphologies of diverse AP expressing neurons from thick coronal sections of adult brains from various IRES-
CreER;Z/AP mice. A, Multipolar neuron in the inferior cerebral cortex. B, Mossy fibers in the cerebellum. C, The cortical pyramidal cell shown in
Figure 3B. D, Cerebellar granule cells. E, a compact cortical pyramidal cell. A–D are from NFL-IRES-CreER;Z/AP brains, and E is from a ChAT-IRES-CreER;Z/
AP brain; the tracing of the cell in E is shown at lower magnification in Figure 5J. A, B, D, and E are traced from 300 um thick sections, and samples
from the corresponding Z-series bright field images are shown. C is traced from a 200 um thick section; a sample from the Z-series image is shown in
Figure 3B. Scale bars: 0.2 mm.
doi:10.1371/journal.pone.0004099.g004
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of recombination at the Z/AP locus that renders it ,1,000 fold less
recombinogenic than other constructs in which a pair of loxP sites
directs excision of an intervening segment of several kilobases [e.g.,
conditional knockout alleles at the Frizzled5 locus [35] and at the
Brn3a and Brn3b loci (T. Badea and J. Nathans, unpublished)]; (3)
the dose and route of administration of 4HT; and (4) a progressive
decrease in Cre-mediated recombination when 4HT is adminis-
tered at later postnatal ages.
Sparse labeling also requires targeting of postmitotic cells to
avoid generating clonally related clusters of neurons. For those
CNS regions in which neuronal proliferation occurs prenatally
Figure 5. Morphologies of cholinergic neurons in an adult ChAT-IRES-CreER;Z/AP brain. Different neurons are color-coded. The mouse
received injections of 4HT on P8 (1 mg), P21 (2 mg), and P28 (2 mg). A–P, tracing of neuronal processes from 16 serial 300 um coronal sections. Q–S
and Figure 4E show bright field images of the AP-stained tissue corresponding to the boxed and lettered regions in D and J. All of the AP-stained
neurons within the 16 sections are shown. Regions in which a high density of AP-labeled processes precluded accurate tracing are indicated by a
semi-opaque grey zone, as shown for the cell in panel R. Cells bodies are indicated by black arrows. Scale bars: 0.2 mm in Q and R, 0.5 mm in S.
doi:10.1371/journal.pone.0004099.g005
Figure 6. Morphologies of AP-labeled neurons in the rostral half of an adult ChAT-IRES-CreER;Z/AP brain. The mouse received injections
of 4HT on P8 (1 mg), P21 (2 mg), and P28 (2 mg). A,B, bright field images of AP-stained tissue corresponding to the boxed regions in J and E,
respectively. C–M, AP-labeled processes traced from eleven serial 300 um coronal sections. Two adjacent neurons with cell bodies in the basal
forebrain (black arrows in panels K and L) and their large axon arbors in the cerebral cortex are shown in red. All other processes are shown in green.
Regions in which a high density of AP-labeled processes precluded accurate tracing are marked by semi-opaque grey zones. Scale bar: 0.5 mm in A,
0.2 mm in B.
doi:10.1371/journal.pone.0004099.g006
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at any postnatal age; for those regions in which neuronal
proliferation continues postnatally (e.g. retina and cerebellum)
4HT injection can be delayed until ,P8–P10. Furthermore, since
expression of the ChAT, NFL, and TH genes is low or undetectable
in proliferating progenitors, Cre-mediated recombination in the
corresponding IRES-CreER knock-in lines should also be low in
proliferating progenitors regardless of the time of 4HT injection.
By contrast, in the case of VAMP2-IRES-CreER;Z/AP mice, 4HT
injection at P2 produced clones of several hundred granule cells in
the cerebellum (data not shown), implying expression of CreER
from the VAMP2 locus in proliferating granule cell progenitors.
Two properties of AP histochemistry are particularly useful for
the morphologic analysis of large neurons: (1) efficient diffusion of
the low-molecular weight histochemical substrates into fixed tissue
and (2) the stability of the AP reaction product, which survives
immersion in the tissue clearing agent benzylbenzoate:benzyl
alcohol (BBBA). These attributes of substrate and product permit
processing and imaging of a small number of relatively thick
sections (200–400 um thickness), thus minimizing the technically
challenging alignment of neuronal processes between sections. We
also note that the NBT/BCIP precipitate does not bleach or fade
with visible light exposure and, if the tissue is stored in ethanol, the
precipitate can be preserved for years with no apparent loss or
diffusion. These attributes facilitate data collection over many
imaging sessions. Although not utilized in the present study, AP
activity can also be visualized by transmission electron microscopy
via the production of a lead-phosphate precipitate, thus facilitating
a correlation between light microscopic and ultrastructural
analyses [27].
Large size and complex morphology of basal forebrain
cholinergic neurons
Cholinergic neurons with cell bodies located in the basal
forebrain modulate cellular activity throughout the cerebral cortex,
with wide-ranging physiologic effects. For example, cholinergic
input modifies the response properties of neurons in primary
sensory cortices, enhances the response to behaviorally significant
stimuli in association areas, facilitates cortical control of motor
output, and regulates vascular tone [36,37]. Current evidence
supports a model in which cholinergic neurotransmission modulates
neuronal excitability but does not carry point-to-point information
as glutamatergic and GABAergic transmission does [36].
Interest in the forebrain cholinergic system has been greatly
stimulated by the observation that postmortem Alzheimer’s disease
brains exhibit a decrease in the number of cell bodies of
cholinergic neurons in the basal forebrain and a parallel loss of
enzymes involved in cholinergic transmission (e.g. ChAT) in the
cerebral cortex [38–41]. Similar losses have also been reported in
patients with Down syndrome, Parkinson’s disease, and a variety
of other progressive dementias [36,42,43]. These findings have led
to the development of drugs to enhance cholinergic transmission
as a strategy to partially ameliorate disease symptoms in patients
with these disorders [44].
Sparse Cre-mediated recombination in ChAT-IRES-CreER;Z/
AP mice permits the visualization of the full axonal and dendritic
Figure 7. Tracing the morphology of a single AP-expressing neuron projecting from the periaqueductal gray to the lateral
hypothalamus in an adult TH-IRES-CreER;Z/AP brain. A–O, Fifteen serial 300 um coronal sections. This is the only AP-expressing neuron in this
hemisphere. The cell body is indicated by the black arrow in N.
doi:10.1371/journal.pone.0004099.g007
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our knowledge, this is the first time that the complete morphology
of these cells has been revealed in any species. Earlier studies in
which individual basal forebrain cholinergic neurons were labeled
by injection of neurobiotin revealed their dendritic arbors but only
incompletely filled their much larger axonal arbors [45]. The
striking finding from the present study is that, for an individual
cholinergic neuron, the axonal arbor is extremely large, with dense
ramifications over a cortical surface area of .2m m
2 in the mouse.
The large size of these cells is consistent with the simple idea that
their loss in a variety of degenerative CNS diseases might reflect a
correspondingly high metabolic burden and/or a high burden of
toxic insults from amyloid deposition or reactive chemical species.
Ideas along these lines have gained wide currency in the context of
motor neuron disease and peripheral sensory neuropathies, with
the enhanced susceptibility to disease in these contexts being
related to the presence of an extremely long axon [46].
Implications for visualizing neuronal morphology and
sub-cellular structure
The most widely used methods for defining the morphologies of
individual mammalian neurons involve fluorescent dye or
neurobiotin filling by intracellular injection. In the simplest version
of these methods, each neuron is identified solely on the basis of
properties that are revealed after micro-electrode penetration:
morphology, physiology, or both. However, this approach is
Figure 8. AP-labeled processes in the hippocampus in an adult NFL-IRES-CreER;Z/AP brain. A–L, Contiguous AP-labeled processes span
eleven serial 300 um sections within the hippocampus. All of the AP labeled processes within the two hippocampi have been traced, but AP-labeled
neurons outside of the hippocampus are not shown. M, anterior hippocampus corresponding to the boxed region in B shows unilateral AP-labeling.
Some residual endogenous alkaline phosphatase activity is seen in the vasculature and choroid plexus. The cell body of this neuron has not been
localized. N,O, Two images from a Z-stack of the region bounded by the pair of black corner marks in M. The processes of the AP-labeled neuron form
a finely spaced meshwork near the surface of the molecular layer of the dentate gyrus. Scale bars: 0.5 mm in M, 0.2 mm in O.
doi:10.1371/journal.pone.0004099.g008
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subset, and it is impractical if that subset is rare.
A more efficient derivative of this method takes advantage of
nondestructive approaches that reveal particular neuronal subsets
in living tissue to guide intracellular tracer injection. For example,
a particular subset of cell bodies can be visualized by retrograde
labeling with fluorescent dextran, a method that has been widely
used to analyze the morphologies of retinal ganglion cells that
project to defined retinorecipient areas in the brain [e.g. ref. 2].
Alternatively, a subset of cell bodies can be visualized based on
expression of a fluorescent protein marker [47]. The critical
constraint in this more sophisticated approach to tracer injection is
the requirement for optical access, making it practical for slice
preparations, retinal flat mounts, or the more superficial layers of
the cerebral cortex, but impractical for deeper brain regions. By
contrast, the genetic alternative to tracer injection reveals neuronal
morphologies based solely on sparse cell-type specific expression of
a reporter.
The sparse labeling approach described here can be easily
extended to Cre-control of other proteins. An especially interesting
extension involves producing fluorescent fusion proteins that
localize to subcellular structures such as synapses, mitochondria,
or the cytoskeleton. This type of labeling has recently been
reported following biolistic transformation of neurons in retina
explants [48,49]. Extending this analysis to neurons labeled in vivo
by CreER-mediated activation of germline reporters would be
particularly interesting in the context of CNS disease models.
Methods
IRES-CreER constructs
Genomic DNA segments encompassing the 39 most exons of the
mouse ChAT, NFL, TH, and VAMP2 genes were isolated from an
ES cell genomic library in bacteriophage lambda (a gift of Dr. Se-
Jin Lee). For each knock-in allele, a cassette consisting of an IRES-
CreER, the pBR322 tetracycline resistance gene (TetR), and a Frt-
flanked phosphoglycerate kinase promotor-neomycin resistance
gene (FNF) was inserted into the 39 untranslated region within a
genomic segment that had been subcloned into a plasmid carrying
a Herpes Simplex Virus thymidine kinase gene. The TetR gene
was included within the IRES-CreER/FNF cassette to facilitate
identification of the final plasmid construct. The restriction site in
the 39 UTR into which the IRES-CreER/TetR/FNF cassette was
inserted, together with the sequence of ten nucleotides on each
side of the insertion sites are as follows. ChAT: Sac I,
GGGCTGGGAGCTCCCTCTGA; NFL: Pci I, AGTCAATA-
CATGTATAATTC;T H : Acc65 I, TGCATAGGGTACCACC-
CACA; VAMP2: BamH I, CTCCCTTGGATCCGTGTGTG.
Following electroporation into ES cells and positive and negative
selection (G418 and gancyclovir, respectively), colonies were
screened by Southern blot hybridization with ,500 bp probes
generated by PCR as shown in Figure 1. Karyotypically normal
ES cells were used for blastocyst injection.
Animal husbandry
Following germline transmission of the targeted allele, the PGK-
neo cassette was excised by crossing to mice expressing Flp in the
germline. Lines were maintained on a mixed Sv1296C57BL/6
background. VAMP2-IRES-CreER homozygotes are inviable, but
the other three IRES-CreER lines can be maintained as
homozygous stocks. All four lines have been deposited at the
Jackson Laboratories and are freely available. Mice were handled
and housed in accordance with the Johns Hopkins University
Animal Care and Use Protocols and IACUC guidelines.
Genotyping
As shown in Figure 1 and Table 1, PCR genotyping with a sense
strand TetR primer (primer C), a sense strand 39 UTR primer 59 of
the IRES-CreER/TetR insertion site (primer A) and a 39 UTR
antisense primer 39 of the IRES-CreER/TetR insertion site (primer
B) produces PCR products of different size for the untargeted
allele and the knock-in allele, thus distinguishing homozygous WT,
heterozygote, and homozygous knock-in genotypes. PCR was
performed with Advantage 2 Polymerase (Clontech, La Jolla, CA)
using 35 cycles of 30 seconds denaturation at 94uC, 30 second
annealing at 60uC, and 1 minute elongation at 72uC. Rapid
testing for the presence of the Z/AP allele was performed by X-gal
staining of a small piece of tail.
4HT injection and tissue processing
These procedures were performed essentially as described in ref.
14. In brief, 4HT was dissolved in ethanol, mixed with sunflower
seed oil (Sigma, St. Louis, MO), centrifuged under vacuum to
remove the ethanol, and delivered as a single intraperitoneal
injection between P0 and P10 at a dose of 0.05–0.4 mg per mouse.
After at least one month, the mice were anesthetized, and
subjected to transcardiac perfusion with 4% paraformaldehyde in
PBS. The brain was set in a block of 3% standard or low-melting
point agarose in PBS and a complete series of 300 um coronal
sections were cut with a vibratome. Brain sections and intact
retinas in PBS were heated in a water bath at 65uC for 75 minutes
to inactivate endogenous AP and, for those embedded in low
melting point agarose, to melt the agarose surrounding the tissue;
heat-inactivated tissues were then reacted in NBT/BCIP over-
night at room temperature with gentle agitation. After washing
and post-fixation, tissues were dehydrated with a graded ethanol
series, and clarified in 2:1 benzylbenzoate:benzyl alcohol (BBBA).
For long-term storage, tissue samples were returned to ethanol.
AP-stained tissues can be stored in ethanol for several years with
no change in appearance.
Table 1. PCR Primers for genotyping.
ChAT-IRES-CreER
Primer A: ACTACTGGATCCAAGAGCTAGAGGCCCAACCAAGCCA
Primer B: ACTACTGAATTCTTCTGAATAGCTGGATGAGATAATC
Primer C: CGCATAGAAATTGCATCAACGCAT
Product sizes: A+B, 540 bp; B+C, 630 bp.
NFL-IRES-CreER
Primer A: ACTACTGAATTCAGAGGAGCAGGTGGCTAAGAAGAAAGA
Primer B: ACTACTGGATCCATTATTATTGTAAACATCTGTGTGATTCA
Primer C: CGCATAGAAATTGCATCAACGCAT
Product sizes: A+B, 333 bp; B+C, 497 bp.
TH-IRES-CreER
Primer A: ACTACTGGATCCAGTTTGACCCGTACACCCTGGCCAT
Primer B: ACTACTGAATTCGGAGACCTTTCCTTCCTTTATTGAGA
Primer C: CGCATAGAAATTGCATCAACGCAT
Product sizes: A+B, 400 bp; B+C, 570 bp.
VAMP2-IRES-CreER
Primer A: CTCGTCCTCCTTTCTCCCCCTCT
Primer B: AGAGAGGTGATGGGAACCTCAGG
Primer C: CGCATAGAAATTGCATCAACGCAT
Product sizes: A+B, 330 bp; B+C, 465 bp.
doi:10.1371/journal.pone.0004099.t001
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Images were captured on a Zeiss Stemi SV11 dissecting
microscope equipped with OpenLab software and a Zeiss Axio
Imager Z1 microscope equipped with a motorized stage and
AxioVision software. Typically, 1 um or 2 um Z-steps were used
to capture grey-scale bright-field or DIC images. As BBBA leads to
tissue shrinkage of circa 30%, a complete Z-stack at 2 um intervals
of what was initially a 300 um section can be captured with ,100
images; the size of the resulting image stack is ,180 Mbytes. For
each vibratome section, a two-dimensional projection of AP-
labeled neurites was obtained by manually tracing over the
electronic images using an electronic stylus (Wacom, Saltama,
Japan) and Illustrator CS2 software.
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